GPT and metabolic dysfunction-associated steatohepatitis: A meta-analysis of four randomized trials involving 134 NAFLD and NASH patients revealed that probiotic therapies can reduce AST, ALT, total cholesterol and TNF-α, and improve insulin resistance in these patients [52].